• How Many Strains of SARS-CoV-2 Exist?

Laboratory products

How Many Strains of SARS-CoV-2 Exist?

New research from Italy has revealed there are at least six strains of SARS-CoV-2, the virus that has swept the globe and infected more than 67 million people worldwide. Working from laboratories at the University of Bologna, a team of researchers identified minimal variability and mutation rates between the six strains, a positive trait that increases the chances of developing effective vaccines.

G strain dominates Europe

Across Italy and Europe, strain G is the most common form of SARS-CoV-2. The strain is a variation of the original L strain that first appeared in Wuhan in late 2019. The sequencing-focussed study is one of the most detailed ever conducted on SARS-CoV-2, with the team analysing more than 48,000 coronavirus genomes identified by laboratory scientists around the world. The findings were published under the title ‘Geographic and Genomic Distribution of SARS-CoV-2 Mutations’ in the journal Frontiers in Microbiology, with study coordinator Federico Giorgi explaining how results were used to map the global spread of virus strains, as well as the development of mutations.

“The SARS-CoV-2 coronavirus is presumably already optimised to affect human beings, and this explains its low evolutionary change," says Giorgi, a researcher at the University of Bologna. “This means that the treatments we are developing, including a vaccine, might be effective against all the virus strains.”

Low mutation rate fuels optimism for effective vaccine

As well as G and L strain, mutated version of SARS-CoV-2 include S strain and V strain identified in January. By the end of February G strain had also mutated into separate strains known as GR and GH. The G family remains most prevalent, with Giorgi confirming it represents around 74% of all analysed gene sequences.

The results are positive, with Giorgi and his team identifying just seven mutations per sample. This is significantly lower than the average variability rate of common influenza, which is more than 50% higher. "Rare genomic mutations are less than 1% of all sequenced genomes," says Giorgi. "However, it is fundamental that we study and analyse them so that we can identify their function and monitor their spread. All countries should contribute to the cause by giving access to data about the virus genome sequences."

From Italy to Slovenia, European universities are pioneers of coronavirus. Find out more about the latest developments in ‘Slovenia Joins the World’s Flagship Neutron Facility, ILL’ which spotlights the newest addition to the coveted Institut Laue-Langevin facility.


Digital Edition

Lab Asia Dec 2025

December 2025

Chromatography Articles- Cutting-edge sample preparation tools help laboratories to stay ahead of the curveMass Spectrometry & Spectroscopy Articles- Unlocking the complexity of metabolomics: Pushi...

View all digital editions

Events

Smart Factory Expo 2026

Jan 21 2026 Tokyo, Japan

Nano Tech 2026

Jan 28 2026 Tokyo, Japan

Medical Fair India 2026

Jan 29 2026 New Delhi, India

SLAS 2026

Feb 07 2026 Boston, MA, USA

Asia Pharma Expo/Asia Lab Expo

Feb 12 2026 Dhaka, Bangladesh

View all events